rs933058944

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_005188.4(CBL):​c.80G>A​(p.Gly27Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000705 in 1,417,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G27V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

CBL
NM_005188.4 missense

Scores

3
9
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.97

Publications

0 publications found
Variant links:
Genes affected
CBL (HGNC:1541): (Cbl proto-oncogene) This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
CBL Gene-Disease associations (from GenCC):
  • CBL-related disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, Genomics England PanelApp
  • juvenile myelomonocytic leukemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.39780328).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005188.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
NM_005188.4
MANE Select
c.80G>Ap.Gly27Glu
missense
Exon 1 of 16NP_005179.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
ENST00000264033.6
TSL:1 MANE Select
c.80G>Ap.Gly27Glu
missense
Exon 1 of 16ENSP00000264033.3
CBL
ENST00000634586.1
TSL:5
c.80G>Ap.Gly27Glu
missense
Exon 1 of 18ENSP00000489218.1
CBL
ENST00000637974.1
TSL:5
c.74G>Ap.Gly25Glu
missense
Exon 1 of 17ENSP00000490763.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.05e-7
AC:
1
AN:
1417870
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
701282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32730
American (AMR)
AF:
0.00
AC:
0
AN:
37932
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25334
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37790
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81076
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5170
European-Non Finnish (NFE)
AF:
9.16e-7
AC:
1
AN:
1091452
Other (OTH)
AF:
0.00
AC:
0
AN:
58794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
29
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.64
D
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.20
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.92
D
M_CAP
Pathogenic
0.79
D
MetaRNN
Benign
0.40
T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
0.0
N
PhyloP100
8.0
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.34
Sift
Uncertain
0.020
D
Sift4G
Uncertain
0.016
D
Polyphen
0.0060
B
Vest4
0.77
MutPred
0.23
Gain of solvent accessibility (P = 0.0411)
MVP
0.89
MPC
2.3
ClinPred
0.92
D
GERP RS
2.5
PromoterAI
0.012
Neutral
Varity_R
0.58
gMVP
0.72
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs933058944; hg19: chr11-119077207; API